A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology -- Giusti et al. 40 (10): 787 Data Supplement

A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology
J Med Genet Giusti et al. 40 (10): 787.

Author Correction

Please note number of errors appear in Table 1. The correct version is available here as a PDF (printer-friendly file). Please note, the changes are highlighted in yellow.

If you do not have Adobe Reader installed on your computer,
you can download this free-of-charge, please Click here

Files in this Data Supplement:

[View PDF] - Table 1 The frequency of BRCA1/2 Ashkenazi founder mutations among Israeli Ashkenazi men diagnosed with incident prostate cancer 1994-1995, and among men age 50 and over with no history of prostate cancer in the Washington Ashkenazi Study (WAS), and in the Molecular Epidemiology of Colorectal Cancer (MECC) study.